Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 481-493

  Gu, Lei ^a   Vogiatzi, Paraskevi ^a   Puhr, Martin ^a   Dagvadorj, Ayush ^a   Lutz, Jacqueline ^a   Ryder, Amy ^a   Addya, Sankar ^a   Fortina, Paolo ^a,b   Cooper, Carlton ^c   Leiby, Benjamin ^d   Dasgupta, Abhijit ^d   Hyslop, Terry ^d   Bubendorf, Lukas ^e   Alanen, Kalle ^f   Mirtti, Tuomas ^f   Nevalainen, Marja T ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF DELAWARE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; DISTANT METASTASIS; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROTUBULE; MOUSE; NONHUMAN; PROSTATE CANCER;

ANIMALS; CARCINOMA; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASE 2; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; STAT5 TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953578552     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0328     Document Type: Article

References (44)

1. Ahonen TJ, Harkonen PL, Laine J, Rui H, Martikainen PM & Nevalainen MT 1999 Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140 5412-5421.
2. Ahonen TJ, Harkonen PL, Rui H & Nevalainen MT 2002 PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro. Endocrinology 143 228-238.
3. Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H & Nevalainen MT 2003 Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. Journal of Biological Chemistry 278 27287-27292.
4. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S et al. 2008 Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14 79-89.
5. Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R & Lacal JC 2001 Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Molecular Biology of the Cell 12 3282-3294.
6. Benitah SA, Valeron PF, Rui H & Lacal JC 2003 STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. Molecular Biology of the Cell 14 40-53.
7. Benjamini Y & Hochberg Y 1995 Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Statistical Methodology) 57 289-300.
8. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R & Korach KS 2000 Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 141 2982-2994.
9. Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B & Blute ML 2002 Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 95 1028-1036.
10. Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T et al. 2007 Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 148 3089-3101.
11. Dagvadorj A, Kirken RA, Leiby B, Karras J & Nevalainen MT 2008a Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clinical Cancer Research 14 1317-1324.
12. Dagvadorj A, Tan SH, Liao Z, Cavalli LR, Haddad BR & Nevalainen MT 2008b Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor. Clinical Cancer Research 14 6062-6072.
13. Falcon S & Gentleman R 2007 Using GOstats to test gene lists for GO term association. Bioinformatics 23 257-258.
14. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5 R80.
15. Goh EL, Pircher TJ & Lobie PE 1998 Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis. Endocrinology 139 4364-4372.
16. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH & Chang WC 2008 Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Research 36 4337-4351.
17. Ihle JN 2001 The Stat family in cytokine signaling. Current Opinion in Cell Biology 13 211-217.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U & Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 249-264.
19. Jeanes A, Gottardi CJ & Yap AS 2008 Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27 6920-6929.
20. Lehr JE & Pienta KJ 1998 Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. Journal of the National Cancer Institute 90 118-123.
21. Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG, Ealley EL, Zhang Y, Nurmi M, Singh B et al. 2004 Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Research 64 4774-4782.
22. Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP & Nevalainen MT 2005 Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clinical Cancer Research 11 5863-5868.
23. Miles FL, Pruitt FL, van Golen KL & Cooper CR 2008 Stepping out of the flow: capillary extravasation in cancer metastasis. Clinical & Experimental Metastasis 25 305-324.
24. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, Gingras S, Hoffmeyer A, Bauer A, Piekorz R, Wang D et al. 2005 Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7 87-99.
25. Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K & Takeichi M 1987 Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329 341-343.
26. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ & Cher ML 1999 Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Research 59 1987-1993. (Pubitemid 29186176)
27. Nevalainen MT, Valve EM, Makela SI, Blauer M, Tuohimaa PJ & Harkonen PL 1991 Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinology 129 612-622.
28. Nevalainen MT, Härkönen PL, Valve EM, Ping W, Nurmi M & Martikainen PM 1993 Hormone regulation of human prostate in organ culture. Cancer Research 53 5199-5207. (Pubitemid 23333388)
29. Nevalainen MT, Valve EM, Ingleton PM & Harkonen PL 1996 Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate. Endocrinology 137 3078-3088.
30. Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J & Harkonen PL 1997a Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB Journal 11 1297-1307. (Pubitemid 27527893)
31. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM & Harkonen PL 1997b Prolactin and prolactin receptors are expressed and functioning in human prostate. Journal of Clinical Investigation 99 618-627. (Pubitemid 27097662)
32. Nevalainen MT, Xie J, Bubendorf L, Wagner KU & Rui H 2002 Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Molecular Endocrinology 16 1108-1124.
33. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G & Rui H 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis. Journal of Clinical Oncology 22 2053-2060.
34. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V & Cao X 2006 Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. Journal of Cell Biology 172 245-257.
35. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A & Kitamura T 1998 Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Molecular and Cellular Biology 18 3871-3879. (Pubitemid 28287910)
36. Orr FW, Wang HH, Lafrenie RM, Scherbarth S & Nance DM 2000 Interactions between cancer cells and the endothelium in metastasis. Journal of Pathology 190 310-329.
37. Ozawa Y, Williams AH, Estes ML, Matsushita N, Boschelli F, Jove R & List AF 2008 Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leukemia Research 32 893-903.
38. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH & Guan KL 2000 Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290 144-147.
39. Singh AS, Macpherson GR, Price DK, Schimel D & Figg WD 2006 Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis. Oncology Reports 15 519-524.
40. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3 Article 3.
41. Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z et al. 2008 Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Research 68 236-248.
42. Timar J, Raso E, Dome B, Li L, Grignon D, Nie D, Honn KV & Hagmann W 2000 Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. International Journal of Cancer 87 37-43.
43. Yamazaki D, Kurisu S & Takenawa T 2005 Regulation of cancer cell motility through actin reorganization. Cancer Science 96 379-386.
44. Yang X, Qiao D, Meyer K & Friedl A 2009 Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Research 69 1668-1677.